Dodecanoate

Dodecanoate

SCHEMBL19253062

CCCCCCCCCCCC(=O)[O-].C[N+](C)(C)CCO

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3GNRHRMPLPDE3APDE3BPDE4APDE4BPDE4CPDE4DPPARASLC5A2

The experimentally established mechanism targets of Dodecanoate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
FABP3 P05413 7/20 0.55
CA1 P00915 1/20 0.52
BBOX1 O75936 2/20 0.48
CES2 O00748 3/20 0.48
CES1 P23141 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Decanoic Acid SCHEMBL580470 1.00 FABP3 (0.55) FABP3CA1BBOX1CES2CES1
Nonanoate SCHEMBL29370695 1.00 FABP3 (0.55) FABP3CA1BBOX1CES2CES1
Stearic Acid SCHEMBL840883 1.00 FABP3 (0.55) FABP3CA1BBOX1CES2CES1
Palmitic Acid SCHEMBL10396224 1.00 FABP3 (0.55) FABP3CA1BBOX1CES2CES1
Octanoic Acid SCHEMBL2761867 1.00 FABP3 (0.55) FABP3CA1BBOX1CES2CES1
Myristic Acid SCHEMBL8588822 1.00 FABP3 (0.55) FABP3CA1BBOX1CES2CES1
Stearic Acid SCHEMBL3459529 0.98 FABP3 (0.53) FABP3CA1BBOX1CES2CES1
Myristic Acid SCHEMBL5317287 0.98 FABP3 (0.53) FABP3CA1BBOX1CES2CES1
Dodecanoate SCHEMBL5320074 0.98 FABP3 (0.53) FABP3CA1BBOX1CES2CES1
Decanoic Acid SCHEMBL5318916 0.98 FABP3 (0.53) FABP3CA1BBOX1CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024040141-A1 COMPOSITION OF MATTER, SYSTEM, AND METHOD FOR ENHANCED MAGNESIUM UPTAKE, RETENTION, AND SYNERGISTIC ACTIONS RMJ HOLDINGS, LLC (US) 2024-02-22 WO claimed
CN-108047014-B Method for extracting and separating coenzyme Q10 by using ionic liquid 浙江大学 2020-07-07 CN claimed
CN-119822959-A Purification method of medium/long carbon chain triglyceride 浙江大学 2025-04-15 CN disclosed
US-20250011651-A1 OIL DISPERSANT FORMULATION, METHODS AND USES THEREOF INSTITUTO SUPERIOR TÉCNICO (PT) 2025-01-09 US disclosed
WO-2024040141-A1 COMPOSITION OF MATTER, SYSTEM, AND METHOD FOR ENHANCED MAGNESIUM UPTAKE, RETENTION, AND SYNERGISTIC ACTIONS RMJ HOLDINGS, LLC (US) 2024-02-22 WO disclosed
WO-2023091038-A1 OIL DISPERSANT FORMULATION, METHODS AND USES THEREOF INSTITUTO SUPERIOR TÉCNICO (PT) 2023-05-25 WO disclosed
CN-108047014-B Method for extracting and separating coenzyme Q10 by using ionic liquid 浙江大学 2020-07-07 CN disclosed
EP-3395368-A1 TRANSDERMAL ABSORPTION ENHANCER AND TRANSDERMAL ABSORPTION ENHANCEMENT AID ASAHI KASEI KABUSHIKI KAISHA (JP) 2018-10-31 EP disclosed
EP-3395369-A1 TRANSDERMAL ABSORPTION ENHANCER AND TRANSDERMAL ABSORPTION ENHANCEMENT AID ASAHI KASEI KABUSHIKI KAISHA (JP) 2018-10-31 EP disclosed
EP-3213769-A1 TRANSDERMAL-ABSORPTION-PROMOTER AND TRANSDERMAL-ABSORPTION-PROMOTING SUPPLEMENT ASAHI KASEI KABUSHIKI KAISHA (JP) 2017-09-06 EP disclosed
US-20170239173-A1 TRANSDERMAL ABSORPTION ENHANCER AND TRANSDERMAL ABSORPTION ENHANCEMENT AID ASAHI KASEI KABUSHIKI KAISHA (JP) 2017-08-24 US disclosed
CN-1854120-A Non-toxic ion liquid its production and use UNIV HEBEI NORMAL (CN) 2006-11-01 CN disclosed
CN-1651089-A Nontoxic ionic liquid, preparation method and application thereof UNIV HEBEI NORMAL (CN) 2005-08-10 CN disclosed